GlassScriptPhysician profile
Kyle Lawrence Cabbell
NPI 1598756934
$2,517.85
in general payments reported to CMS, 2019-2025
23 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $83.04 · 2021: $155 · 2022: $392 · 2023: $295 · 2024: $44.01 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,227.97 | 2019-2021 | |
| Stryker Corporation | $169.56 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $157.45 | 2019-2022 | |
| Nuvasive, INC. | $120.54 | 2022 | |
| Alexion Pharmaceuticals, INC. | $116.36 | 2023 | Soliris |
| Providence Medical Technology, INC. | $110.30 | 2023-2025 | |
| Boston Scientific Corporation | $100.95 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Intrinsic Therapeutics | $91.21 | 2022 | |
| Orthofix Medical, INC. | $69.11 | 2019-2023 | Spinal-Stim, Spinal-Stim |
| Integra Lifesciences Corporation | $58.29 | 2019-2024 | Integra, Integra Duo, Microfrance |
| Saluda Medical Americas, INC. | $43.86 | 2023 | Evoke Scs |
| Vertex Pharmaceuticals Incorporated | $37.03 | 2025 | |
| Medtronic USA, INC. | $33.63 | 2019-2020 | |
| Spineology INC. | $26.09 | 2020 | |
| Amgen INC. | $23.97 | 2024 | Evenity, Prolia |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $23.86 | 2022 | |
| Si-Bone, INC. | $19.68 | 2019 | |
| Ethicon US, LLC | $16.60 | 2025 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, Vistaseal |
| Abbvie INC. | $15.20 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2022 | |
| Medtronic, INC. | $14.74 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.86 | 2023 | Andexxa |
| Collegium Pharmaceutical, INC. | $12.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Cabbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.